Soe H. Ann

Ulsan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Association between gallstones and subclinical coronary atherosclerosis: An observational study with propensity score matching.

Association between gallstones and subclinical coronary atherosclerosis: An observational study with propensity score matching.

Journal: PloS one

Published: June 07, 2026

Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.

Cardiorenal Outcomes of Empagliflozin Versus Dapagliflozin in Secondary Prevention Among Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Nationwide Cohort Study.

Journal: Diabetes, obesity & metabolism

Published: April 16, 2026

Sex differences in the association of lipoprotein(a) with subclinical coronary atherosclerosis in asymptomatic individuals.

Sex differences in the association of lipoprotein(a) with subclinical coronary atherosclerosis in asymptomatic individuals.

Journal: Journal of cardiology

Published: April 04, 2026

Degree of hypertension and subclinical coronary atherosclerosis in asymptomatic individuals without cardiovascular disease.

Degree of hypertension and subclinical coronary atherosclerosis in asymptomatic individuals without cardiovascular disease.

Journal: PloS one

Published: January 12, 2026

Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study.

Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study.

Journal: Diabetes research and clinical practice

Published: November 05, 2025

Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus.

Differential impact of lipoprotein(a) on subclinical coronary atherosclerosis in asymptomatic individuals with and without diabetes mellitus.

Journal: Scientific reports

Published: November 14, 2024

Interaction between age and therapeutic approach on outcome in older patients with patent foramen ovale-associated stroke.

Interaction between age and therapeutic approach on outcome in older patients with patent foramen ovale-associated stroke.

Journal: Revista espanola de cardiologia (English ed.)

Published: June 29, 2024

Association between smoking status and subclinical coronary atherosclerosis in asymptomatic Korean individuals.

Association between smoking status and subclinical coronary atherosclerosis in asymptomatic Korean individuals.

Journal: Epidemiology and health

Published: April 02, 2024

Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.

Prognostic impact of beta-blocker use by N-terminal pro-brain natriuretic peptide level in acute heart failure patients.

Journal: ESC heart failure

Published: March 09, 2024

Depression and Subclinical Coronary Atherosclerosis in Adults Without Clinical Coronary Artery Disease.

Depression and Subclinical Coronary Atherosclerosis in Adults Without Clinical Coronary Artery Disease.

Journal: Journal of the American Heart Association

Published: December 08, 2023

Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale.

Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale.

Journal: Journal of stroke

Published: October 03, 2023

Impact of Scoring Balloon Angioplasty on Lesion Preparation for DCB Treatment of Coronary Lesions.

Impact of Scoring Balloon Angioplasty on Lesion Preparation for DCB Treatment of Coronary Lesions.

Journal: Journal of clinical medicine

Published: August 30, 2023

Showing 1-12 of 72

Last Updated: 09/26/2026